Dover vs NOV
DOV and NOV side by side, both in construction, mining, and materials handling. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DOV and NOV compare
Dover is the larger company, worth 4.1 times as much as NOV ($28.0B against $6.9B).
On earnings, Dover is cheaper: it trades at 25.0× trailing earnings, against 74.2× for NOV.
Dover grew revenue faster over the last twelve months (7.6% versus −1.7% for NOV).
Dover keeps more of each dollar of sales as profit, with a net margin of 13.5% compared with 1.1% at NOV.
Both pay dividends: Dover yields 1.0% and NOV 2.3%.
Dover scores higher on the StockData Score (16 against 9 for NOV), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DOV | NOV |
|---|---|---|
| Size and price | ||
| Market cap | $28.0B | $6.9B |
| Share price | $207.74 | $19.29 |
| Change, 1 year | 14.9% | 26.0% |
| Change, 5 years | 21.3% | 31.6% |
| Beta (5Y) | 0.98 | 0.80 |
| Employees | 24K | 35K |
| StockData Score | ||
| Total score | 16 (better) | 9 |
| Valuation score | 1 | 2 (better) |
| Growth score | 2 (better) | 0 |
| Performance score | 4 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 25.0× (better) | 74.2× |
| P/S | 3.3× | 0.8× (better) |
| P/B | 3.6× | 1.1× (better) |
| EV/EBITDA | 16.6× | 9.3× (better) |
| P/FCF | 23.8× | 12.2× (better) |
| PEG | 10.96 | – |
| FCF yield | 4.2% | 8.2% (better) |
| Fair value | $166.75 | $20.51 |
| Margin of safety | −24.6% | 5.9% (better) |
| Growth | ||
| Revenue growth (TTM) | 7.6% (better) | −1.7% |
| Revenue growth, 5Y average | 3.9% | 7.5% (better) |
| Net income growth (TTM) | −50.5% (better) | −79.8% |
| EPS growth (TTM) | −49.9% (better) | −78.7% |
| EPS growth, 5Y average | 11.1% | – |
| Profitability | ||
| Gross margin | 39.6% (better) | 20.5% |
| Operating margin | 16.9% (better) | 5.1% |
| Net margin | 13.5% (better) | 1.1% |
| FCF margin | 14.0% (better) | 6.5% |
| Return on equity | 15.0% (better) | 1.5% |
| Return on invested capital | 11.5% (better) | 3.2% |
| Financial health | ||
| Debt / equity | 0.51 | 0.27 (better) |
| Net debt / EBITDA | 1.21 | 0.67 (better) |
| Interest coverage | 12.5× (better) | 5.0× |
| Current ratio | 1.98 | 2.42 (better) |
| Altman Z-score | 5.47 (better) | 2.02 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.0% | 2.3% (better) |
| Payout ratio | 24.8% | 160% |
| Years of dividend growth | 16 (better) | 2 |
| Dividend growth, 5Y average | 1.00% | 59.1% (better) |
| Buyback yield | 2.0% | 4.3% (better) |
| Shareholder yield | 3.0% | 6.5% (better) |
| Ownership | ||
| Held by institutions | 91.4% | 109% |
| Held by insiders | 0.47% | 1.2% |
| Insider net buying, 12 months | −$20.0M | −$3.6M (better) |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 3.7% | 7.6% |
Go deeper
- DOV stock overview
- DOV income statement
- DOV valuation and score
- NOV stock overview
- NOV income statement
- NOV valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.